Renal disease pathophysiology and treatment: Contributions from the rat

DMM Disease Models and Mechanisms

Volumn 9, Issue 12, 2016, Pages 1419-1433

  Mullins, Linda J ^a   Conway, Bryan R ^a   Menzies, Robert I ^a   Denby, Laura ^a   Mullins, John J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Chronic kidney disease; Diabetic nephropathy; End organ damage; Genetically modified rats; Rat; Renal transplantation

Indexed keywords

PURINERGIC P2X7 RECEPTOR;

ACUTE DISEASE; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DISEASE COURSE; DNA MODIFICATION; GENETIC MODEL; HYPERTENSION; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY TRANSPLANTATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REVIEW; ANIMAL; DISEASE MODEL; HUMAN;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; RATS;

EID: 85008339435     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.027276     Document Type: Review

References (158)

1. Advani, A., Gilbert, R. E., Thai, K., Gow, R. M., Langham, R. G., Cox, A. J., Connelly, K. A., Zhang, Y., Herzenberg, A. M., Christensen, P. K. et al. (2009). Expression, localization, and function of the thioredoxin system in diabetic nephropathy. J. Am. Soc. Nephrol. 20, 730-741
2. Aitman, T. J., Critser, J. K., Cuppen, E., Dominiczak, A., Fernandez-Suarez, X. M., Flint, J., Gauguier, D., Geurts, A. M., Gould, M., Harris, P. C. et al. (2008). Progress and prospects in rat genetics: a community view. Nat. Genet. 40, 516-522
3. Aitman, T., Dhillon, P. and Geurts, A. M. (2016). A RATional choice for translational research? Dis. Model. Mech. 9, 1069-1072
4. Ashek, A., Menzies, R. I., Mullins, L. J., Bellamy, C.O. C., Harmar, A. J., Kenyon, C. J., Flatman, P. W., Mullins, J. J. and Bailey, M. A. (2012). Activation of thiazide-sensitive co-transport by angiotensin II in the cyp1a1-Ren2 hypertensive rat. PLoS ONE 7, e36311
5. Atanur, S. S., Birol, I., Guryev, V., Hirst, M., Hummel, O., Morrissey, C., Behmoaras, J., Fernandez-Suarez, X. M., Johnson, M. D., McLaren, W. M. et al. (2010). The genome sequence of the spontaneously hypertensive rat: analysis and functional significance. Genome Res. 20, 791-803
6. Bachmann, S., Peters, J., Engler, E., Ganten, D. and Mullins, J. (1992). Transgenic rats carrying the mouse renin gene-morphological characterization of a low-renin hypertension model. Kidney Int. 41, 24-36
7. Bader, M., Zhao, Y., Sander, M., Lee, M. A., Bachmann, J., Bohm, M., Djavidani, B., Peters, J., Mullins, J. J. and Ganten, D. (1992). Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats. Hypertension 19, 681-686
8. Bartlett, R., Stokes, L. and Sluyter, R. (2014). The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease. Pharmacol. Rev. 66, 638-675
9. Basile, D. P., Anderson, M. D. and Sutton, T. A. (2012). Pathophysiology of acute kidney injury. Compr. Physiol. 2, 1303-1353
10. Becker, G. J. and Hewitson, T. D. (2013). Animal models of chronic kidney disease: useful but not perfect. Nephrol. Dial. Transplant. 28, 2432-2438
11. Berkman, J. and Rifkin, H. (1973). Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson): report of a case. Metabolism 22, 715-722
12. Bernstein, K. E., Shen, X. Z., Gonzalez-Villalobos, R. A., Billet, S., Okwan-Duodu, D., Ong, F. S. and Fuchs, S. (2011). Different in vivo functions of the two catalytic domains of angiotensin-converting enzyme (ACE). Curr. Opin. Pharmacol. 11, 105-111
13. Béroniade, V. C., Lefebvre, R. and Falardeau, P. (1987). Unilateral nodular diabetic glomerulosclerosis: recurrence of an experiment of nature. Am. J. Nephrol. 7, 55-59
14. Betz, B. B., Jenks, S. J., Cronshaw, A. D., Lamont, D. J., Cairns, C., Manning, J. R., Goddard, J., Webb, D. J., Mullins, J. J., Hughes, J. et al. (2016). Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes. Kidney Int. 89, 1125-1135
15. Bhatt, D. L., Kandzari, D. E., O'Neill,W.W., D'Agostino, R., Flack, J. M., Katzen, B. T., Leon,M. B., Liu, M., Mauri, L., Negoita, M. et al. (2014). A controlled trial of renal denervation for resistant hypertension. N. Engl. J. Med. 370, 1393-1401
16. Brezis, M., Heyman, S. N., Dinour, D., Epstein, F. H. and Rosen, S. (1991). Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys. J. Clin. Invest. 88, 390-395
17. Bucaloiu, I. D., Kirchner, H. L., Norfolk, E. R., Hartle, J. E., and Perkins, R. M. (2012). Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int. 81, 477-485
18. Buehr, M., Meek, S., Blair, K., Yang, J., Ure, J., Silva, J., McLay, R., Hall, J., Ying, Q.-L. and Smith, A. (2008). Capture of authentic embryonic stem cells from rat blastocysts. Cell 135, 1287-1298
19. Burlaka, I., Nilsson, L. M., Scott, L., Holtbäck, U., Eklöf, A.-C., Fogo, A. B., Brismar, H. and Aperia, A. (2016). Prevention of apoptosis averts glomerular tubular disconnection and podocyte loss in proteinuric kidney disease. Kidney Int. 90, 135-148
20. Cantaluppi, V., Gatti, S., Medica, D., Figliolini, F., Bruno, S., Deregibus, M. C., Sordi, A., Biancone, L., Tetta, C. and Camussi, G. (2012). Microvesicles derived from endothelial progenitor cells protect the kidney from ischemiareperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 82, 412-427
21. Cavaglieri, R. C., Martini, D., Sogayar, M. C. and Noronha, I. L. (2009). Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. Transplant. Proc. 41, 947-951
22. Cervenka, L., Wang, C.-T., Mitchell, K. D. and Navar, L. G. (1999). Proximal tubular angiotensin II levels and renal functional responses to AT1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats. Hypertension 33, 102-107
23. Chandraker, A., Azuma, H., Nadeau, K., Carpenter, C. B., Tilney, N. L., Hancock, W. W. and Sayegh, M. H. (1998). Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection. J. Clin. Invest. 101, 2309-2318
24. Chawla, L. S., Amdur, R. L., Amodeo, S., Kimmel, P. L. and Palant, C. E. (2011). The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int. 79, 1361-1369
25. Cheewatrakoolpong, B., Gilchrest, H., Anthes, J. C. and Greenfeder, S. (2005). Identification and characterization of splice variants of the human P2X7 ATP channel. Biochem. Biophys. Res. Commun. 332, 17-27
26. Choi, S., Park, M., Kim, J., Hwang, S., Park, S. and Lee, Y. (2009). The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev. 18, 521-529
27. Conger, J. D., Robinette, J. B. and Hammond, W. S. (1991). Differences in vascular reactivity in models of ischemic acute renal failure. Kidney Int. 39, 1087-1097
28. Conway, B. R., Rennie, J., Bailey, M. A., Dunbar, D. R., Manning, J. R., Bellamy, C. O., Hughes, J. and Mullins, J. J. (2012). Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathy. J. Am. Soc. Nephrol. 23, 405-411
29. Conway, B. R., Betz, B., Sheldrake, T. A., Manning, J. R., Dunbar, D. R., Dobyns, A., Hughes, J. and Mullins, J. J. (2014). Tight blood glycaemic and blood pressure control in experimental diabetic nephropathy reduces extracellular matrix production without regression of fibrosis. Nephrology 19, 802-813
30. Cooper, M. E., Allen, T. J., Macmillan, P., Bach, L., Jerums, G. and Doyle, A. E. (1988). Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat. Am. J. Hypertens. 1, 5-10
31. Dahl, L. K., Heine, M. and Tassinari, L. (1962). Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature 194, 480-482
32. Heer, E., Davidoff, A., van der Wal, A., van Geest, M. and Paul, L. C. (1994). Chronic renal allograft rejection in the rat. Transplantation-induced antibodies against basement membrane antigens. Lab. Invest. 70, 494-502
33. Denby, L., Ramdas, V., McBride, M. W., Wang, J., Robinson, H., McClure, J., Crawford, W., Lu, R., Hillyard, D. Z., Khanin, R. et al. (2011). miR-21 and miR-214 are consistently modulated during renal injury in rodent models.Am. J. Pathol. 179, 661-672
34. Doorschodt, B. M., Teubner, A., Kobayashi, E. and Tolba, R. H. (2014). Promising future for the transgenic rat in transplantation research. Transplant. Rev. 28, 155-162
35. Evans, L. C., Ivy, J. R., Wyrwoll, C., McNairn, J. A., Menzies, R. I., Christensen, T. H., Al-Dujaili, E. A. S., Kenyon, C. J., Mullins, J. J., Seckl, J. R. et al. (2016). Conditional deletion of Hsd11b2 in the brain causes salt appetite and hypertension. Circulation 133, 1360-1370
36. Falke, L. L., Gholizadeh, S., Goldschmeding, R., Kok, R. J. and Nguyen, T. Q. (2015). Diverse origins of the myofibroblast-implications for kidney fibrosis. Nat. Rev. Nephrol. 11, 233-244
37. Ferenbach, D. A. and Bonventre, J. V. (2015). Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat. Rev. Nephrol. 11, 264-276
38. Finne, K., Vethe, H., Skogstrand, T., Leh, S., Dahl, T. D., Tenstad, O., Berven, F. S., Reed, R. K. and Vikse, B. E. (2014). Proteomic analysis of formalin-fixed paraffin-embedded glomeruli suggests depletion of glomerular filtration barrier proteins in two-kidney, one-clip hypertensive rats. Nephrol. Dial. Transplant. 29, 2217-2227
39. Finne, K., Marti, H.-P., Leh, S., Skogstrand, T., Vethe, H., Tenstad, O., Berven, F. S., Scherer, A. and Vikse, B. E. (2016). Proteomic analysis of minimally damaged renal tubular tissue from two-kidney-one-clip hypertensive rats demonstrates extensive changes compared to tissue from controls. Nephron 132, 70-80
40. Fioretto, P., Steffes, M. W., Sutherland, D. E. R., Goetz, F. C. and Mauer, M. (1998). Reversal of lesions of diabetic nephropathy after pancreas transplantation. N. Engl. J. Med. 339, 69-75
41. Fioretto, P., Sutherland, D. E. R., Najafian, B. and Mauer, M. (2006). Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients. Kidney Int. 69, 907-912
42. Fleig, S. V. and Humphreys, B. D. (2014). Rationale of mesenchymal stem cell therapy in kidney injury. Nephron Clin. Pract. 127, 75-80
43. Fukuda, A., Chowdhury, M. A., Venkatareddy, M. P.,Wang, S. Q., Nishizono, R., Suzuki, T., Wickman, L. T., Wiggins, J. E., Muchayi, T., Fingar, D. et al. (2012a). Growth-dependent podocyte failure causes glomerulosclerosis. J. Am. Soc. Nephrol. 23, 1351-1363
44. Fukuda, A., Wickman, L. T., Venkatareddy, M. P., Sato, Y., Chowdhury, M. A., Wang, S. Q., Shedden, K. A., Dysko, R. C., Wiggins, J. E. and Wiggins, R. C. (2012b). Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int. 81, 40-55
45. Garcia Diaz, A. I., Moyon, B., Coan, P. M., Alfazema, N., Venda, L., Woollard, K. and Aitman, T. (2016). New Wistar Kyoto and spontaneously hypertensive rat transgenic models with ubiquitous expression of green fluorescent protein. Dis. Model. Mech. 9, 463-471
46. Gatti, S., Bruno, S., Deregibus, M. C., Sordi, A., Cantaluppi, V., Tetta, C. and Camussi, G. (2011). Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol. Dial. Transplant. 26, 1474-1483
47. Geurts, A. M., Cost, G. J., Freyvert, Y., Zeitler, B., Miller, J. C., Choi, V. M., Jenkins, S. S., Wood, A., Cui, X., Meng, X. et al. (2009). Knockout rats via embryo microinjection of zinc-finger nucleases. Science 325, 433
48. Gidlöf, O., Smith, J. G., Melander, O., Lövkvist, H., Hedblad, B., Engström, G., Nilsson, P., Carlson, J., Berglund, G., Olsson, S. et al. (2012). A common missense variant in the ATP receptor P2X7 is associated with reduced risk of cardiovascular events. PLoS ONE 7, e37491
49. Gilbert, R. E., Zhang, Y., Williams, S. J., Zammit, S. C., Stapleton, D. I., Cox, A. J., Krum, H., Langham, R. and Kelly, D. J. (2012). A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat. PLoS ONE 7, e47160
50. Goldblatt, H., Lynch, J., Hanzal, R. F. and Summerville,W.W. (1934). Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med. 59, 347-379
51. Gruden, G., Zonca, S., Hayward, A., Thomas, S., Maestrini, S., Gnudi, L. and Viberti, G. C. (2000). Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes 49, 655-661
52. Guron, G. and Friberg, P. (2000). An intact renin-angiotensin system is a prerequisite for normal renal development. J. Hypertens. 18, 123-137
53. Hancock,W.W., Whitley,W. D., Baldwin,W. M., and Tilney, N. L. (1992). Cells, cytokines, adhesion molecules, and humoral responses in a rat model of chronic renal allograft rejection. Transplant Proc. 24, 2315-2316
54. Hansell, P., Welch, W. J., Blantz, R. C. and Palm, F. (2013). Determinants of kidney oxygen consumption and their relationship to tissue oxygen tension in diabetes and hypertension. Clin. Exp. Pharmacol. Physiol. 40, 123-137
55. Hartner, A., Cordasic, N., Klanke, B., Wittmann, M., Veelken, R. and Hilgers, K. F. (2007). Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension, not on diabetes. Am. J. Physiol. Renal. Physiol. 292, F820-F827
56. Helle, F., Hultstrom, M., Skogstrand, T., Palm, F. and Iversen, B. M. (2008). Angiotensin II-induced contraction is attenuated by nitric oxide in afferent arterioles from the nonclipped kidney in 2K1C. Am. J. Physiol. Renal Physiol. 296, F78-F86
57. Hennino, M.-F., Buob, D., Van der Hauwaert, C., Gnemmi, V., Jomaa, Z., Pottier, N., Savary, G., Drumez, E., Noël, C., Cauffiez, C. et al. (2016). miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy. Sci. Rep. 6, 27209
58. Hering, D., Marusic, P., Walton, A. S., Duval, J., Lee, R., Sata, Y., Krum, H., Lambert, E., Peter, K., Head, G. et al. (2016). Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension. Int. J. Cardiol. 202, 388-393
59. Heyman, S. N., Brezis, M., Epstein, F. H., Spokes, K., Silva, P. and Rosen, S. (1991). Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int. 40, 632-642
60. Heyman, S. N., Darmon, D., Goldfarb, M., Bitz, H., Shina, A., Rosen, S. and Brezis, M. (2000). Endotoxin-induced renal failure. I. A role for altered renal microcirculation. Exp. Nephrol. 8, 266-274
61. Hill, G. S. (2008). Hypertensive nephrosclerosis. Curr. Opin. Nephrol. Hypertens. 17, 266-270
62. Hocher, B., Liefeldt, L., Thone-Reineke, C., Orzechowski, H.-D., Distler, A., Bauer, C. and Paul, M. (1996). Characterization of the renal phenotype of transgenic rats expressing the human endothelin-2 gene. Hypertension 28, 196-201
63. Howard, L. L., Patterson, M. E., Mullins, J. J. and Mitchell, K. D. (2005). Saltsensitive hypertension develops after transient induction of ANG II-dependent hypertension in Cyp1a1-Ren2 transgenic rats. Am. J. Physiol. Renal. Physiol. 288, F810-F815
64. Hu, J., Zhu, Q., Xia, M., Guo, T. L.,Wang, Z., Li, P.-L., Han,W.-Q., Yi, F. and Li, N. (2014). Transplantation of mesenchymal stem cells into the renal medulla attenuated salt-sensitive hypertension in Dahl S rat. J. Mol. Med. 92, 1139-1145
65. Hultström, M. (2012). Development of structural kidney damage in spontaneously hypertensive rats. J. Hypertens. 30, 1087-1091
66. Iwai, S., Sakonju, I., Okano, S., Teratani, T., Kasahara, N., Yokote, S., Yokoo, T. and Kobayash, E. (2014). Impact of ex vivo administration of mesenchymal stem cells on the function of kidney grafts from cardiac death donors in rat. Transplant. Proc. 46, 1578-1584
67. Jain, S., Furness, P. N. and Nicholson, M. L. (2000). The role of transforming growth factor beta in chronic renal allograft nephropathy. Transplantation 69, 1759-1766
68. Janssen, U., Riley, S. G., Vassiliadou, A., Floege, J. and Phillips, A. O. (2003). Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy. Kidney Int. 63, 2162-2170
69. Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M. and Yang, C.-W. (2013). Chronic kidney disease: global dimension and perspectives. Lancet 382, 260-272
70. Ji, X., Naito, Y., Hirokawa, G., Weng, H., Hiura, Y., Takahashi, R. and Iwai, N. (2012). P2X(7) receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertens. Res. 35, 173-179
71. Jiang, L.-H., Baldwin, J. M., Roger, S. and Baldwin, S. A. (2013). Insights into the molecular mechanisms underlying mammalian P2X7 receptor functions and contributions in diseases, revealed by structural modeling and single nucleotide polymorphisms. Front. Pharmacol. 4, 55
72. Ju, W., Nair, V., Smith, S., Zhu, L., Shedden, K., Song, P. X. K., Mariani, L. H., Eichinger, F. H., Berthier, C. C., Randolph, A. et al. (2015). Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. Sci. Transl. Med. 7, 316ra193
73. Kantachuvesiri, S., Haley, C. S., Fleming, S., Kurian, K., Whitworth, C. E., Wenham, P., Kotelevtsev, Y. and Mullins, J. J. (1999). Genetic mapping of modifier loci affecting malignant hypertension in TGRmRen2 rats. Kidney Int. 56, 414-420
74. Kantachuvesiri, S., Fleming, S., Peters, J., Peters, B., Brooker, G., Lammie, A. G., McGrath, I., Kotelevtsev, Y. and Mullins, J. J. (2001). Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease. J. Biol. Chem. 276, 36727-36733
75. Kelly, D. J., Wilkinson-Berka, J. L., Allen, T. J., Cooper, M. E. and Skinner, S. L. (1998). A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR). Kidney Int. 54, 343-352
76. Kelly, D. J., Zhang, Y., Moe, G., Naik, G. and Gilbert, R. E. (2007). Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats. Diabetologia 50, 2398-2404
77. Khan, N. A., Herman, R. J., Quinn, R. R., Rabkin, S. W., Ravani, P., Tobe, S. W., Feldman, R. D., Wijeysundera, H. C, Padwal, R. S. (2014). Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program. Can. J. Cardiol. 30, 16-21
78. Kim, Y. H., Goyal, M., Kurnit, D., Wharram, B., Wiggins, J., Holzman, L., Kershaw, D. andWiggins, R. (2001). Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int. 60, 957-968
79. Klinkhammer, B. M., Kramann, R., Mallau, M., Makowska, A., van Roeyen, C. R., Rong, S., Buecher, E. B., Boor, P., Kovacova, K., Zok, S. et al. (2014). Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potential. PLoS ONE 9, e92115
80. Kramann, R. and Humphreys, B. D. (2014). Kidney pericytes: roles in regeneration and fibrosis. Semin. Nephrol. 34, 374-383
81. Kunter, U., Rong, S., Boor, P., Eitner, F., Muller-Newen, G., Djuric, Z., van Roeyen, C. R., Konieczny, A., Ostendorf, T., Villa, L. et al. (2007). Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J. Am. Soc. Nephrol. 18, 1754-1764
82. Kunter, U., Rong, S., Moeller, M. J. and Floege, J. (2011). Mesenchymal stem cells as a therapeutic approach to glomerular diseases: benefits and risks. Kidney Int. Suppl. 1, 68-73
83. Lee, S.-Y., Kim, S. I. and Choi, M. E. (2015). Therapeutic targets for treating fibrotic kidney diseases. Transl. Res. 165, 512-530
84. Lewis, E. J., Hunsicker, L. G., Bain, R. P. and Rohde, R. D. (1993). The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N. Engl. J. Med. 329, 1456-1462
85. Li, B., Morioka, T., Uchiyama, M. and Oite, T. (2006). Bone marrow cell infusion ameliorates progressive glomerulosclerosis in an experimental rat model. Kidney Int. 69, 323-330
86. Li, P., Tong, C., Mehrian-Shai, R., Jia, L., Wu, N., Yan, Y., Maxson, R. E., Schulze, E. N., Song, H., Hsieh, C.-L. et al. (2008). Germline competent embryonic stem cells derived from rat blastocysts. Cell 135, 1299-1310
87. Li, D., Qiu, Z., Shao, Y., Chen, Y., Guan, Y., Liu, M., Li, Y., Gao, N., Wang, L., Lu, X. et al. (2013). Heritable gene targeting in the mouse and rat using a CRISPRCas system. Nat. Biotechnol. 31, 681-683
88. Liangos, O., Wald, R., O'Bell, J. W., Price, L., Pereira, B. J. and Jaber, B. L. (2006). Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin. J. Am. Soc. Nephrol. 1, 43-51
89. Lindenmeyer, M. T., Kretzler, M., Boucherot, A., Berra, S., Yasuda, Y., Henger, A., Eichinger, F., Gaiser, S., Schmid, H., Rastaldi, M. P. et al. (2007). Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J. Am. Soc. Nephrol. 18, 1765-1776
90. Liu, X., Bellamy, C. O. C., Bailey, M. A., Mullins, L. J., Dunbar, D. R., Kenyon, C. J., Brooker, G., Kantachuvesiri, S., Maratou, K., Ashek, A. et al. (2009). Angiotensin-converting enzyme is a modifier of hypertensive end organ damage. J. Biol. Chem. 284, 15564-15572
91. Lu, Y., Liu, X., Shi, S., Su, H., Bai, X., Cai, G., Yang, F., Xie, Z., Zhu, Y., Zhang, Y. et al. (2012). Bioinformatics analysis of proteomic profiles during the process of anti-Thy1 nephritis. Mol. Cell. Proteomics 11, 008755
92. Lurbe, E., Redon, J., Kesani, A., Pascual, J. M., Tacons, J., Alvarez, V. and Batlle, D. (2002). Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N. Engl. J. Med. 347, 797-805
93. Ma, Y., Ma, J., Zhang, X., Chen,W., Yu, L., Lu, Y., Bai, L., Shen, B., Huang, X. and Zhang, L. (2014a). Generation of eGFP and Cre knockin rats by CRISPR/Cas9. FEBS J. 281, 3779-3790
94. Ma, Y., Zhang, X., Shen, B., Lu, Y., Chen, W., Ma, J., Bai, L., Huang, X. and Zhang, L. (2014b). Generating rats with conditional alleles using CRISPR/Cas9. Cell Res. 24, 122-125
95. Magee, C. C., Azuma, H., Knoflach, A., Denton, M. D., Chandraker, A., Iyer, S., Buelow, R. and Sayegh, M. (1999). In vitro and in vivo immunomodulatory effects of RDP1258, a novel synthetic peptide. J. Am. Soc. Nephrol. 10, 1997-2005
96. McMahon, E. J., Bauer, J. D., Hawley, C. M., Isbel, N. M., Stowasser, M., Johnson, D.W. and Campbell, K. L. (2013). A randomized trial of dietary sodium restriction in CKD. J. Am. Soc. Nephrol. 24, 2096-2103
97. Mehran, R. and Nikolsky, E. (2006). Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int., 69, S11-S15
98. Menzies, R. I., Unwin, R. J., Dash, R. K., Beard, D. A., Cowley, A.W., Jr, Carlson, B. E., Mullins, J. J. and Bailey, M. A. (2013). Effect of P2X4 and P2X7 receptor antagonism on the pressure diuresis relationship in rats. Front. Physiol. 4, 305
99. Menzies, R. I., Howarth, A. R., Unwin, R. J., Tam, F.W., Mullins, J. J. and Bailey, M. A. (2015a). Inhibition of the purinergic P2X7 receptor improves renal perfusion in angiotensin-II-infused rats. Kidney Int. 88, 1079-1087
100. Menzies, R. I., Unwin, R. J. and Bailey, M. A. (2015b). Renal P2 receptors and hypertension. Acta Physiol. 213, 232-241
101. Menzies, R. I., Tam, F. W., Unwin, R. J. and Bailey, M. A. (2016). Purinergic signaling in kidney disease. Kidney Int. [Epub ahead of print], doi:10.1016/j. kint.2016.08.029
102. Micallef, L., Vedrenne, N., Billet, F., Coulomb, B., Darby, I. A. and Desmouliere, A. (2012). The myofibroblast, multiple origins for major roles in normal and pathological tissue repair. Fibrogenesis Tissue Repair 5, S5
103. Milani, C. J., Kobori, H., Mullins, J. J. and Mitchell, K. D. (2010). Enhanced urinary angiotensinogen excretion in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension. Am. J. Med. Sci. 340, 389-394
104. Miyazawa, K., Kikuchi, S., Fukuyama, J., Hamano, S. and Ujiie, A. (1995). Inhibition of PDGF-and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis 118, 213-221
105. Mogensen, C. E. (1998). Combined high blood pressure and glucose in type 2 diabetes: double jeopardy. British trial shows clear effects of treatment, especially blood pressure reduction. BMJ 317, 693-694
106. Moreno, C., Hoffman, M., Stodola, T. J., Didier, D. N., Lazar, J., Geurts, A. M., North, P. E., Jacob, H. J. and Greene, A. S. (2011). Creation and characterization of a renin knockout rat. Hypertension 57, 614-619
107. Mullins, J. J., Peters, J. and Ganten, D. (1990). Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344, 541-544
108. Mullins, L. J., Kenyon, C. J., Bailey, M. A., Conway, B. R., Diaz, M. E. and Mullins, J. J. (2015). Mineralocorticoid excess or glucocorticoid insufficiency: renal and metabolic phenotypes in a rat Hsd11b2 knockout model. Hypertension 66, 667-673
109. Narayan, P., Duan, B., Jiang, K., Li, J., Paka, L., Yamin, M., Friedman, S. L.,Weir, M. R. and Goldberg, I. D. (2016). Late intervention with the small molecule BB3 mitigates post-ischemic kidney injury. Am. J. Physiol. Renal Physiol. 311, F352-F361
110. Nazeer, K., Janech, M. G., Lin, J. J.-C., Ryan, K. J., Arthur, J. M. and Budisavljevic, M. N. (2009). Changes in protein profiles during course of experimental glomerulonephritis. Am. J. Physiol. Renal Physiol. 296, F186-F193
111. Noris, M., Mister, M., Pezzotta, A., Azzollini, N., Cassis, P., Benigni, A., Gagliardini, E., Perico, N. and Remuzzi, G. (2003). ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are established. Kidney Int. 64, 2253-2261
112. Okamoto, K. and Aoki, K. (1963). Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 27, 282-293
113. Okamoto, K., Aoki, K., Nosaka, S. and Fukushima, M. (1964). Cardiovascular diseases in the spontaneously hypertensive rat. Jpn. Circ. J. 28, 943-952
114. Okamura, T., Miyazaki, M., Inagami, T. and Toda, N. (1986). Vascular reninangiotensin system in two-kidney, one clip hypertensive rats. Hypertension 8, 560-565
115. Ortiz, R. M., Graciano, M. L., Mullins, J. J. and Mitchell, K. D. (2007). Aldosterone receptor antagonism alleviates proteinuria, but not malignant hypertension, in Cyp1a1-Ren2 transgenic rats. Am. J. Physiol. Renal Physiol. 293, F1584-F1591
116. Palm, F., Connors, S. G., Mendonca, M., Welch, W. J. and Wilcox, C. S. (2008). Angiotensin II type 2 receptors and nitric oxide sustain oxygenation in the clipped kidney of early Goldblatt hypertensive rats. Hypertension 51, 345-351
117. Palm, F., Onozato, M., Welch, W. J. and Wilcox, C. S. (2010). Blood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-kidney, 1-clip rats: effects of tempol and Angiotensin blockade. Hypertension 55, 298-304
118. Parving, H.-H., Persson, F., Lewis, J. B., Lewis, E. J., Hollenberg, N. K. and Investigators, A. S. (2008). Aliskiren combined with losartan in type 2 diabetes and nephropathy. N. Engl. J. Med. 358, 2433-2446
119. Parving, H.-H., Brenner, B. M., McMurray, J. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Persson, F., Desai, A. S., Nicolaides, M. et al. (2012). Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N. Engl. J. Med. 367, 2204-2213
120. Paul, L. C., Muralidharan, J., Muzaffar, S. A., Manting, E. H., Valentin, J. F., de Heer, E. and Kashgarian, M. (1998). Antibodies against mesangial cells and their secretory products in chronic renal allograft rejection in the rat. Am. J. Pathol. 152, 1209-1223
121. Perkins, B. A., Ficociello, L. H., Silva, K. H., Finkelstein, D. M.,Warram, J. H. and Krolewski, A. S. (2003). Regression of microalbuminuria in type 1 diabetes. N. Engl. J. Med. 348, 2285-2293
122. Peters, J., Münter, K., Bader, M., Hackenthal, E., Mullins, J. J. and Ganten, D. (1993). Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II, and calcium. J. Clin. Invest. 91, 742-747
123. Peti-Peterdi, J., Kidokoro, K. and Riquier-Brison, A. (2016). Intravital imaging in the kidney. Curr. Opin. Nephrol. Hypertens. 25, 168-173
124. Polichnowski, A. J., Lan, R., Geng, H., Griffin, K. A., Venkatachalam, M. A. and Bidani, A. K. (2014). Severe renal mass reduction impairs recovery and promotes fibrosis after AKI. J. Am. Soc. Nephrol. 25, 1496-1507
125. Pozdzik, A. A., Giordano, L., Li, G., Antoine, M.-H., Quellard, N., Godet, J., De Prez, E., Husson, C., Declèves, A.-E., Arlt, V. M. et al. (2016). Blocking TGFbeta signaling pathway preserves mitochondrial proteostasis and reduces early activation of PDGFRbeta+ pericytes in aristolochic acid induced acute kidney injury in wistar male rats. PLoS ONE 11, e0157288
126. Pravenec, M. and Křen, V. (2005). Genetic analysis of complex cardiovascular traits in the spontaneously hypertensive rat. Exp. Physiol. 90, 273-276
127. Prieto,M. C., Williams, D. E., Liu, L., Kavanagh, K. L., Mullins, J. J. and Mitchell, K. D. (2011). Enhancement of renin and prorenin receptor in collecting duct of Cyp1a1-Ren2 rats may contribute to development and progression of malignant hypertension. Am. J. Physiol. Renal. Physiol. 300, F581-F588
128. Ralevic, V. and Burnstock, G. (1998). Receptors for purines and pyrimidines. Pharmacol. Rev. 50, 413-492
129. Rosenberger, C., Rosen, S. and Heyman, S. N. (2006). Renal parenchymal oxygenation and hypoxia adaptation in acute kidney injury. Clin. Exp. Pharmacol. Physiol. 33, 980-988
130. Salant, D. J., Belok, S., Stilmant, M. M., Darby, C. and Couser, W. G. (1979). Determinants of glomerular localization of subepithelial immune deposits: effects of altered antigen to antibody ratio, steroids, vasoactive amine antagonists, and aminonucleoside of puromycin on passive Heymann nephritis in rats. Lab. Invest. 41, 89-99
131. Saran, R., Li, Y., Robinson, B., Ayanian, J., Balkrishnan, R., Bragg-Gresham, J., Chen, J. T. L., Cope, E., Gipson, D., He, K. et al. (2015). US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States. Am. J. Kidney. Dis. 66, S1-305
132. Schrimpf, C. and Duffield, J. S. (2011). Mechanisms of fibrosis: the role of the pericyte. Curr. Opin. Nephrol. Hypertens. 20, 297-305
133. Schrimpf, C., Teebken, O. E., Wilhelmi, M. and Duffield, J. S. (2014). The role of pericyte detachment in vascular rarefaction. J. Vasc. Res. 51, 247-258
134. Shao, W., Miyata, K., Katsurada, A., Satou, R., Seth, D. M., Rosales, C. B., Prieto, M. C., Mitchell, K. D. and Navar, L. G. (2016). Increased angiotensinogen expression, urinary angiotensinogen excretion, and tissue injury in nonclipped kidneys of two-kidney, one-clip hypertensive rats. Am. J. Physiol. Renal Physiol. 311, F278-F290
135. Shimoyama, M., Laulederkind, S. J. F., De Pons, J., Nigam, R., Smith, J. R., Tutaj, M., Petri, V., Hayman, G. T., Wang, S.-J., Ghiasvand, O. et al. (2016). Exploring human disease using the Rat Genome Database. Dis. Model. Mech. 9, 1089-1095
136. Shrestha, B. and Haylor, J. (2014). Experimental rat models of chronic allograft nephropathy: a review. Int. J. Nephrol. Renovasc. Dis. 2014, 315-322
137. Skogstrand, T., Leh, S., McClure, J., Dashti, M., Iversen, B. M., Graham, D., McBride, M. W. and Hultström, M. (2015). Identification of a common molecular pathway in hypertensive renal damage: comparison of rat and human gene expression profiles. J. Hypertens. 33, 584-596; discussion 596
138. Solini, A., Iacobini, C., Ricci, C., Chiozzi, P., Amadio, L., Pricci, F., Di Mario, U., Di Virgilio, F. and Pugliese, G. (2005). Purinergic modulation of mesangial extracellular matrix production: role in diabetic and other glomerular diseases. Kidney Int. 67, 875-885
139. Stevens, P. E., O'Donoghue, D. J., de Lusignan, S., Van Vlymen, J., Klebe, B., Middleton, R., Hague, N., New, J. and Farmer, C. K. T. (2007). Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int. 72, 92-99
140. Stokes, L., Scurrah, K., Ellis, J. A., Cromer, B. A., Skarratt, K. K., Gu, B. J., Harrap, S. B. and Wiley, J. S. (2011). A loss-of-function polymorphism in the human P2X4 receptor is associated with increased pulse pressure. Hypertension 58, 1086-1092
141. Szebenyi, K., Furedi, A., Kolacsek, O., Csohany, R., Prokai, A., Kis-Petik, K., Szabo, A., Bosze, Z., Bender, B., Tovari, J. et al. (2015). Visualization of calcium dynamics in kidney proximal tubules. J. Am. Soc. Nephrol. 26, 2731-2740
142. Tanaka, T., Kojima, I., Ohse, T., Inagi, R., Miyala, T., Ingelfinger, J. R., Fujita, T. and Nangaku, M. (2005). Hypoxia-inducible factor modulates tubular cell survival in cisplatin nephrotoxicity. Am. J. Physiol. Renal. Physiol. 289, F1123-F1133
143. Taylor, S. R. J., Turner, C. M., Elliott, J. I., McDaid, J., Hewitt, R., Smith, J., Pickering, M. C., Whitehouse, D. L., Cook, H. T., Burnstock, G. et al. (2009). P2X7 deficiency attenuates renal injury in experimental glomerulonephritis. J. Am. Soc. Nephrol. 20, 1275-1281
144. Terashima, H., Kato, M., Yasumo, H., Tsuchida, H., Mizuno, M. and Sada, T. (2010). A sensitive short-term evaluation of antifibrotic effects using newly established type I collagen reporter transgenic rats. Am. J. Physiol. Renal Physiol. 299, F792-F801
145. Tesson, L., Usal, C., Ménoret, S., Leung, E., Niles, B. J., Remy, S., Santiago, Y., Vincent, A. I., Meng, X., Zhang, L. et al. (2011). Knockout rats generated by embryo microinjection of TALENs. Nat. Biotechnol. 29, 695-696
146. Tonelli, M.,Wiebe, N., Culleton, B., House, A., Rabbat, C., Fok, M., McAlister, F. and Garg, A. X. (2006). Chronic kidney disease and mortality risk: a systematic review. J. Am. Soc. Nephrol. 17, 2034-2047
147. Turner, C. M., Tam, F.W. K., Lai, P.-C., Tarzi, R. M., Burnstock, G., Pusey, C. D., Cook, H. T. and Unwin, R. J. (2007). Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritis. Nephrol. Dial. Transplant. 22, 386-395
148. Ueda, K. and Nagase, M. (2014). Mineralocorticoid receptor activation as an etiological factor in kidney diseases. Clin. Exp. Nephrol. 18, 16-23
149. Urt-Filho, A. F., Oliveira, R. J., Hermeto, L. C., Pesarini, J. R., David, N., Cantero, W. B., Falcao, G., Marks, G. and Antoniolli-Silva, A. C. (2016). Mesenchymal stem cell therapy promotes the improvement and recovery of renal function in a preclinical model. Genet. Mol. Biol. 39, 290-299
150. Wang, Y., He, J., Pei, X. and Zhao,W. (2013). Systematic review and meta-analysis of mesenchymal stem/stromal cells therapy for impaired renal function in small animal models. Nephrology 18, 201-208
151. Watanabe, Y., Yoshida, M., Yamanishi, K., Yamamoto, H., Okuzaki, D., Nojima, H., Yasunaga, T., Okamura, H., Matsunaga, H. and Yamanishi, H. (2015). Genetic analysis of genes causing hypertension and stroke in spontaneously hypertensive rats: gene expression profiles in the kidneys. Int. J. Mol. Med. 36, 712-724
152. Wharram, B. L., Goyal, M., Wiggins, J. E., Sanden, S. K., Hussain, S., Filipiak, W. E., Saunders, T. L., Dysko, R. C., Kohno, K., Holzman, L. B. et al. (2005). Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J. Am. Soc. Nephrol. 16, 2941-2952
153. White, E., Hildemann, W. H. and Mullen, Y. (1969). Chronic kidney allograft reactions in rats. Transplantation 8, 602-617
154. Whitworth, C. E., Fleming, S., Cumming, A. D., Morton, J. J., Burns, N. J. T., Williams, B. C. and Mullins, J. J. (1994). Spontaneous development of malignant phase hypertension in transgenic Ren-2 rats. Kidney Int. 46, 1528-1532
155. Yao, Y., Fomison-Nurse, I. C., Harrison, J. C., Walker, R. J., Davis, G. and Sammut, I. A. (2014). Chronic bilateral renal denervation attenuates renal injury in a transgenic rat model of diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 307, F251-F262
156. Zatz, R., Meyer, T.W., Rennke, H. G. and Brenner, B. M. (1985). Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc. Natl. Acad. Sci. USA 82, 5963-5967
157. Zatz, R., Dunn, B. R., Meyer, T. W., Anderson, S., Rennke, H. G. and Brenner, B. M. (1986). Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J. Clin. Invest. 77, 1925-1930
158. Zuo, Y., Chun, B., Potthoff, S. A., Kazi, N., Brolin, T. J., Orhan, D., Yang, H.-C., Ma, L.-J., Kon, V., Myöhänen, T. et al. (2013). Thymosin beta4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis. Kidney Int. 84, 1166-1175